This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Saggia MG, Borges LG.Review of the Decisions of Health Technology Assessment Agencies for Capecitabine for the Treatment of Colorectal Cancer. 12th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research: abstr. PCN167, 24 Oct 2009. Available from: URL: http://www.ispor.org/Events/Index.aspx?eventId=30
Saggia MG, Borges LG.Review of the Decisions of Health Technology Assessment Agencies for Capecitabine for the Treatment of Breast Cancer. 12th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research: abstr. PCN169, 24 Oct 2009. Available from: URL: http://www.ispor.org/Events/Index.aspx?eventId=30
Rights and permissions
About this article
Cite this article
Literature supports capecitabine for breast and colorectal cancer. Pharmacoecon. Outcomes News 591, 7 (2009). https://doi.org/10.2165/00151234-200905910-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905910-00011